Cadrenal Therapeutics 强调研究支持12-LOX抑制在减少肥胖和2型糖尿病炎症中的作用

美股速递
Yesterday

Cadrenal Therapeutics 重点介绍了一项研究,该研究支持通过抑制12-脂氧合酶(12-LOX)来减轻肥胖及2型糖尿病相关的炎症反应。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10